Galera Therapeutics Inc. (NASDAQ:GRTX) Shares Surged 0.29% In A Week – But Can It Maintain Its Gains? – Marketing Sentinel
Home  »  Technologies   »  Galera Therapeutics Inc. (NASDAQ:GRTX) Shares Surg...

Galera Therapeutics Inc. (NASDAQ:GRTX) Shares Surged 0.29% In A Week – But Can It Maintain Its Gains?

In last trading session, Galera Therapeutics Inc. (NASDAQ:GRTX) saw 0.85 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $3.44 trading at $0.17 or 5.20% at ring of the bell on the day assigns it a market valuation of $96.77M. That closing price of GRTX’s stock is at a discount of -277.62% from its 52-week high price of $12.99 and is indicating a premium of 65.41% from its 52-week low price of $1.19. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.73 million shares which gives us an average trading volume of 12.69 million if we extend that period to 3-months.

For Galera Therapeutics Inc. (GRTX), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 1.70. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.75 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Galera Therapeutics Inc. (NASDAQ:GRTX) trade information

Upright in the green during last session for gaining 5.20%, in the last five days GRTX remained trading in the green while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $3.44 price level, adding 10.18% to its value on the day. Galera Therapeutics Inc.’s shares saw a change of -25.05% in year-to-date performance and have moved 0.29% in past 5-day. Galera Therapeutics Inc. (NASDAQ:GRTX) showed a performance of 18.62% in past 30-days. Number of shares sold short was 0.61 million shares which calculate 0.03 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $12.25 to the stock, which implies a rise of 71.92% to its current value. Analysts have been projecting $4.00 as a low price target for the stock while placing it at a high target of $20.00. It follows that stock’s current price would drop -481.4% in reaching the projected high whereas dropping to the targeted low would mean a loss of -16.28% for stock’s current value.

Galera Therapeutics Inc. (GRTX) estimates and forecasts

Statistics highlight that Galera Therapeutics Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -61.95% of value to its shares in past 6 months, showing an annual growth rate of -8.72% while that of industry is 7.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 6.30% in the current quarter and calculating 1.30% increase in the next quarter.

In 2022, company’s earnings growth rate is likely to be around -25.30% while estimates for its earnings growth in next 5 years are of 18.40%.

GRTX Dividends

Galera Therapeutics Inc. is more likely to be releasing its next quarterly report between March 09 and March 14 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Galera Therapeutics Inc. (NASDAQ:GRTX)’s Major holders

Insiders are in possession of 13.12% of company’s total shares while institution are holding 67.30 percent of that, with stock having share float percentage of 77.46%. Investors also watch the number of corporate investors in a company very closely, which is 67.30% institutions for Galera Therapeutics Inc. that are currently holding shares of the company. NEA Management Company, LLC is the top institutional holder at GRTX for having 4.36 million shares of worth $35.34 million. And as of Sep 29, 2021, it was holding 16.50% of the company’s outstanding shares.

The second largest institutional holder is Sofinnova Investments, Inc., which was holding about 3.08 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 11.66% of outstanding shares, having a total worth of $24.98 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, Vanguard Total Stock Market Index Fund and Tekla Healthcare Opportunities Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 0.33 million shares of worth $2.66 million or 1.24% of the total outstanding shares. The later fund manager was in possession of 0.31 million shares on Sep 29, 2021, making its stake of worth around $2.55 million in the company or a holder of 1.19% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam